13. Revenue and Geographic Information

 

The Company has two classifications of revenue: Original Equipment Manufacturer (“OEM”) Channel and the Commercial Channel. In the OEM Channel, the Company is responsible for development and manufacturing of products sold to the Company’s OEM partners governed by long-term agreements, but the Company does not control sales, marketing, or pricing with end users. Revenue from the Company’s U.S. OA Pain Management business and the Non-Orthopedic businesses is included in the OEM Channel. In the Commercial Channel, the Company has full responsibility for sales, marketing, and pricing of products through its commercial leaders, direct sales representatives, and independent distributors. Revenue from the Company’s Regenerative Solutions and international OA Pain Management businesses is included in the Commercial Channel.

 

 

 

Product revenue by product family is as follows:

 

   

Years Ended December 31,

 
   

2025

   

2024

   

2023

 
   

Revenue

   

Percentage of
Product
Revenue

   

Revenue

   

Percentage of
Product
Revenue

   

Revenue

   

Percentage of
Product
Revenue

 

OEM Channel

  $ 64,406       57 %   $ 77,770       65 %   $ 84,645       70 %

Commercial Channel

    48,413       43 %     42,137       35 %     36,147       30 %

Total

  $ 112,819       100 %   $ 119,907       100 %   $ 120,792       100 %

 

Product revenue from the Company’s sole significant customer, J&J MedTech, as a percentage of the Company’s total product revenue was 50%, 57%, and 62% for the years ended December 31, 2025, 2024, and 2023, respectively.

 

Total revenue by geographic location based on the location of the customer in total and as a percentage of total revenue are as follows:

 

   

Years Ended December 31,

 
   

2025

   

2024

   

2023

 
   

Total

   

Percentage of

   

Total

   

Percentage of

   

Total

   

Percentage of

 
   

Revenue

   

Revenue

   

Revenue

   

Revenue

   

Revenue

   

Revenue

 

Geographic Location:

                                               

United States

  $ 70,058       62 %   $ 82,446       69 %   $ 86,911       72 %

Europe

    22,214       20 %     19,403       16 %     17,313       14 %

Other

    20,547       18 %     18,058       15 %     16,568       14 %

Total

  $ 112,819       100 %   $ 119,907       100 %   $ 120,792       100 %

 

Net long-lived assets, consisting primarily of net property and equipment, are subject to geographic risks because they are generally difficult to move and to effectively utilize in another geographic area in a reasonable time period and because they are relatively illiquid. Net tangible long-lived assets by principal geographic areas are as follows:

 

   

As of December 31,

 
   

2025

   

2024

 

United States

  $ 39,469     $ 37,964  

Italy

    853       1,001  

United Kingdom

    2       29  

Total

  $ 40,324     $ 38,994  

 

 

Historical Timeline

Fiscal YearFiled
2025Mar 3, 2026Showing above
2024Mar 17, 2025
2023Mar 15, 2024
2022Mar 16, 2023
2021Mar 11, 2022
2020Mar 5, 2021

About Revenue Disclosures

Revenue disclosures under ASC 606 explain how a company identifies performance obligations, allocates transaction prices, and determines when revenue is recognized. This section is essential for understanding whether reported revenue reflects genuine economic activity or aggressive accounting choices. Analysts examine the mix of point-in-time versus over-time recognition, which directly affects revenue timing and comparability.

Key signals: rising contract liabilities (deferred revenue) suggest strong future revenue visibility, while declining contract assets may indicate slowing project milestones. Watch for variable consideration estimates — rebates, returns, and performance bonuses that require management judgment. Significant changes in disaggregated revenue by geography or product line can reveal shifting business mix before it appears in headline numbers. Compare revenue growth against contract liability growth to assess sustainability, and scrutinize any changes in the timing of recognition that coincide with earnings pressure.